Xue Meng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Epidermal Growth Factor Receptor

Genome Wide Identification

Radiation Induced

Top Venues

Thoracic cancer

Cancer management and research

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yanan Wang, Zhenhua Gao, Wen Zhao, Hongxin Li, Xue Meng, Jisheng Li
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer. Thoracic cancer 15 (8) (2024)
Yanan Wang, Zhenhua Gao, Wen Zhao, Hongxin Li, Xue Meng, Jisheng Li
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer. Thoracic cancer (2024)
Yanan Wang, Zhenhua Gao, Wen Zhao, Hongxin Li, Xue Meng, Jisheng Li
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer. Thoracic cancer 15 (8) (2024)
Ying Fu, Qing Liu, Xiaohan Wang, Liangchao Sun, Xiao Han, Xue Meng
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Yanan Wang, Zhenhua Gao, Wen Zhao, Hongxin Li, Xue Meng, Jisheng Li
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer. Thoracic cancer 15 (8) (2024)
Xiao Han, Jun Guo, Lingyu Li, Yong Huang, Xue Meng, Linlin Wang, Hui Zhu, Xiangjiao Meng, Qian Shao, Xing Li, Yan Zhang, Jin Wang, Yanhua Chen, Yingjie Zhang, Yiru Chen, Changbin Zhu, Zhehai Wang
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial. Signal transduction and targeted therapy 9 (1) (2024)
Leilei Wu, Zhenshan Zhang, Shuo Li, Linping Ke, Jinming Yu, Xue Meng
Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy. Cancer management and research 12 (2020)